FHC
HZNP

First Horizon Corporation’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

First Horizon Corporation’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$44K Hold
470
– – ﹤0.01% 402
2021
Q1 		$43K Sell
470
-33
-7% -$2.79K ﹤0.01% 398
2020
Q4 		$36K Sell
503
-50
-9% -$3.72K ﹤0.01% 407
2020
Q3 		$42K Buy
+553
New +$38K ﹤0.01% 373

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

First Horizon Corporation's HZNP Position: Q2 2021 in Review

First Horizon Corporation held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q2 2021 at 470 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

First Horizon Corporation first reported a position in HZNP in Q3 2020 and has held it in 4 quarters since. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

  • First Horizon Corporation held 470 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $44K as of Q2 2021.
  • First Horizon Corporation left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q2 2021.
  • Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #402 holding.
  • First Horizon Corporation first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and has held it in 4 quarters since.
  • 526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.